Anja Bråthen Kristoffersen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anja Bråthen Kristoffersen has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Asia-Sophia Wolf
Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway
3 shared publications - Guri Solum
Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway
3 shared publications - Siri Mjaaland
Norwegian Institute of Public Health
3 shared publications Anthony Ravussin
Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway
2 shared publications- Birgitte Freiesleben de Blasio
Norwegian Institute of Public Health, Oslo, Norway
2 shared publications - Gunnar Rø
Department for Method Development and Analytics Norwegian Institute for Public Health Oslo Norway
2 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Wiley in Zoonoses and Public Health
- Vol. 73 (4) , 336-347
A Retrospective Cross‐Sectional Study (2009–2023): Exploring Influenza A( H1N1 )pdm09 Antibody Time Series in Humans and Swine and Vaccine Coverage in Two Target Groups
Introduction: Swine may act as ‘epidemiological bridges’ and reservoirs for the emergence of novel zoonotic influenza viruses with pandemic potential. While bidirectional exchange of influenza A viruses at the swine–human interface is well recognised, data on the extent of interspecies transmission are limited. Methods: We analysed the post‐seasonal geometric mean titre (GMT) of influenza A(H1N1)pdm09 antibodies in humans and the seasonal prevalence of influenza A(H1N1)pdm09 antibodies in unvaccinated swine from 2009/2010–2022/2023 per county in Norway to search for evidence of interspecies transmission. We explored correlations at the national and individual county level and investigated possible associations by running a negative binomial regression model. Additionally, we distributed an influenza vaccination questionnaire to veterinarians and farmers working with swine to assess vaccination uptake and calculated total response rates per county and overall. Results: The time series of H1N1pdm09 antibodies from humans and swine show significant positive correlations both across (0.8 Pearson correlation coefficient) and within certain individual counties, with especially high correlations in Innlandet (0.9), Vestland (0.8) and Rogaland (0.7) Counties. Our regression analysis revealed a significant positive association between the annual GMT of H1N1pdm09 antibodies in humans, the annual seroprevalence of H1N1pdm09 antibodies in swine, and the density of swine farms in counties. Vaccination uptake was 39% and 50% in farmers and veterinarians, respectively. Conclusions: Our findings indicate a temporal relationship between the disease in humans and swine; suggesting spillover, environmental factors facilitating disease spread, and/or indirect relationships driven by unknown factors. Impacts: The time series of H1N1pdm09 antibodies in humans and swine shows significant correlations. Regression analysis links GMT of H1N1pdm09 antibodies in humans to seroprevalence of H1N1pdm09 in swine and density of swine farms. This indicates a temporal relationship possibly due to spillover, shared risk factors or indirect relationships driven by unknown factors. The influenza vaccination survey showed a 39% uptake among farmers and 50% among swine veterinarians.
- 19 March 2026
- Published by Wiley in Zoonoses and Public Health
- Vol. 73 (4) , 336-347
Open AccessA Retrospective Cross‐Sectional Study (2009–2023): Exploring Influenza A( H1N1 )pdm09 Antibody Time Series in Humans and Swine and Vaccine Coverage in Two Target Groups
Introduction: Swine may act as ‘epidemiological bridges’ and reservoirs for the emergence of novel zoonotic influenza viruses with pandemic potential. While bidirectional exchange of influenza A viruses at the swine–human interface is well recognised, data on the extent of interspecies transmission are limited. Methods: We analysed the post‐seasonal geometric mean titre (GMT) of influenza A(H1N1)pdm09 antibodies in humans and the seasonal prevalence of influenza A(H1N1)pdm09 antibodies in unvaccinated swine from 2009/2010–2022/2023 per county in Norway to search for evidence of interspecies transmission. We explored correlations at the national and individual county level and investigated possible associations by running a negative binomial regression model. Additionally, we distributed an influenza vaccination questionnaire to veterinarians and farmers working with swine to assess vaccination uptake and calculated total response rates per county and overall. Results: The time series of H1N1pdm09 antibodies from humans and swine show significant positive correlations both across (0.8 Pearson correlation coefficient) and within certain individual counties, with especially high correlations in Innlandet (0.9), Vestland (0.8) and Rogaland (0.7) Counties. Our regression analysis revealed a significant positive association between the annual GMT of H1N1pdm09 antibodies in humans, the annual seroprevalence of H1N1pdm09 antibodies in swine, and the density of swine farms in counties. Vaccination uptake was 39% and 50% in farmers and veterinarians, respectively. Conclusions: Our findings indicate a temporal relationship between the disease in humans and swine; suggesting spillover, environmental factors facilitating disease spread, and/or indirect relationships driven by unknown factors. Impacts: The time series of H1N1pdm09 antibodies in humans and swine shows significant correlations. Regression analysis links GMT of H1N1pdm09 antibodies in humans to seroprevalence of H1N1pdm09 in swine and density of swine farms. This indicates a temporal relationship possibly due to spillover, shared risk factors or indirect relationships driven by unknown factors. The influenza vaccination survey showed a 39% uptake among farmers and 50% among swine veterinarians.
- Open Access
- 8 March 2025
- Published by Elsevier in Public Health
- Vol. 242, 131-138
A multi-model approach to estimate excess mortality in the Nordics, 2020–2023
- 8 March 2025
- Published by Elsevier in Public Health
- Vol. 242, 131-138
Open AccessA multi-model approach to estimate excess mortality in the Nordics, 2020–2023
- Open Access
- 29 November 2024
- Published by Springer Nature in npj Vaccines
- Vol. 9 (1) , 1-10
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly
Heterogeneity in vaccine response, particularly in vulnerable populations like the elderly, represents a significant public health challenge. We conducted an in-depth examination of immune cell profiles before and after SARS-CoV-2 vaccination utilizing mass cytometry in a cohort of healthy Norwegian seniors (65–80 years). We have demonstrated that higher pre-vaccination frequencies of CD27+IgD- class-switched memory B cells and subsets of CD27-CD24+CD38+ transitional B cells were associated with a robust vaccine response. Post-vaccination, high responders exhibited increased frequencies of IFN-γ+CD4+ T cells with antigen recall and a concurrent decrease in CCR6(+) TH cell subset frequencies compared to low responders. The presence of a γδ T cell subset displaying polyfunctional cytokine responses was also associated with better vaccine response in the elderly. This in-depth profiling sheds light on inherent differences in immune cell frequencies and functions that may offer insights for targeted vaccination strategies in older populations.
- 29 November 2024
- Published by Springer Nature in npj Vaccines
- Vol. 9 (1) , 1-10
Open AccessMass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly
Heterogeneity in vaccine response, particularly in vulnerable populations like the elderly, represents a significant public health challenge. We conducted an in-depth examination of immune cell profiles before and after SARS-CoV-2 vaccination utilizing mass cytometry in a cohort of healthy Norwegian seniors (65–80 years). We have demonstrated that higher pre-vaccination frequencies of CD27+IgD- class-switched memory B cells and subsets of CD27-CD24+CD38+ transitional B cells were associated with a robust vaccine response. Post-vaccination, high responders exhibited increased frequencies of IFN-γ+CD4+ T cells with antigen recall and a concurrent decrease in CCR6(+) TH cell subset frequencies compared to low responders. The presence of a γδ T cell subset displaying polyfunctional cytokine responses was also associated with better vaccine response in the elderly. This in-depth profiling sheds light on inherent differences in immune cell frequencies and functions that may offer insights for targeted vaccination strategies in older populations.
- Open Access
- 28 October 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (9) , 2560-2569
Spatial and demographic heterogeneity in excess mortality in the United States, 2020-2023: a multimodel approach
In this study, we assessed the overall impact of the COVID-19 pandemic in the United States between 2020 and 2023 through estimates of excess all-cause mortality. Monthly mortality rates over a 19-year period, stratified by age, sex, and state of residence, were used to predict expected mortality for the pandemic years. A combination of models—2 timeseries, a spatial random-effects and a generalized additive—was used to better capture uncertainty. Results indicate that the national excess mortality for the United States decreased in 2023 to 157 000 (95% prediction interval: 35 000-282 000) from 502 000 (436 000-567 000), 574 000 (484 000-666 000) and 377 000 (264 000-484 000) during the years 2020-2022, respectively. Unlike in previous years, deaths with COVID-19 as the underlying cause of death possibly accounted for all excess deaths during 2023. While for the older age groups (>75 years), the year 2020—before vaccines were available—had the highest excess mortality rate, and the 2 younger age groups had the highest excess mortality in 2021. In each age group, women were estimated to have consistently lower excess mortality than men. West Virginia had the highest age-standardized excess mortality among all states in 2021 and 2022. Our findings demonstrate the value of a multimodel approach in capturing heterogeneity in excess mortality.
- 28 October 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (9) , 2560-2569
Open AccessSpatial and demographic heterogeneity in excess mortality in the United States, 2020-2023: a multimodel approach
In this study, we assessed the overall impact of the COVID-19 pandemic in the United States between 2020 and 2023 through estimates of excess all-cause mortality. Monthly mortality rates over a 19-year period, stratified by age, sex, and state of residence, were used to predict expected mortality for the pandemic years. A combination of models—2 timeseries, a spatial random-effects and a generalized additive—was used to better capture uncertainty. Results indicate that the national excess mortality for the United States decreased in 2023 to 157 000 (95% prediction interval: 35 000-282 000) from 502 000 (436 000-567 000), 574 000 (484 000-666 000) and 377 000 (264 000-484 000) during the years 2020-2022, respectively. Unlike in previous years, deaths with COVID-19 as the underlying cause of death possibly accounted for all excess deaths during 2023. While for the older age groups (>75 years), the year 2020—before vaccines were available—had the highest excess mortality rate, and the 2 younger age groups had the highest excess mortality in 2021. In each age group, women were estimated to have consistently lower excess mortality than men. West Virginia had the highest age-standardized excess mortality among all states in 2021 and 2022. Our findings demonstrate the value of a multimodel approach in capturing heterogeneity in excess mortality.
- Open Access
- 10 September 2024
- Published by Elsevier in EBioMedicine
- Vol. 108, 105317
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
- 10 September 2024
- Published by Elsevier in EBioMedicine
- Vol. 108, 105317
Open AccessT cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
- Open Access
- 1 March 2024
- Published by Springer Nature in Research Square
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly
Heterogeneity in vaccine response, particularly in vulnerable populations like the elderly, represents a significant public health challenge. We conducted an in-depth examination of immune cell profiles before and after SARS-CoV-2 vaccination utilizing mass cytometry in a cohort of healthy Norwegian seniors (65–80 years). We have demonstrated that higher pre-vaccination frequencies of CD27+IgD− class-switched memory B cells and subsets of CD27−CD24+CD38+ transitional B cells were associated with a robust vaccine response. Post-vaccination, high responders exhibited increased frequencies of IFN-γ+CD4+ T cells with antigen recall and a concurrent decrease in TH17 cell subset frequencies compared to low responders. The presence of a γδ T cell subset displaying polyfunctional cytokine responses was also associated with better vaccine response in the elderly. This comprehensive analysis sheds light on inherent differences in immune cell frequencies and functions that should offer insights for targeted vaccination strategies in older populations.
- 1 March 2024
- Published by Springer Nature in Research Square
Open AccessMass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly
Heterogeneity in vaccine response, particularly in vulnerable populations like the elderly, represents a significant public health challenge. We conducted an in-depth examination of immune cell profiles before and after SARS-CoV-2 vaccination utilizing mass cytometry in a cohort of healthy Norwegian seniors (65–80 years). We have demonstrated that higher pre-vaccination frequencies of CD27+IgD− class-switched memory B cells and subsets of CD27−CD24+CD38+ transitional B cells were associated with a robust vaccine response. Post-vaccination, high responders exhibited increased frequencies of IFN-γ+CD4+ T cells with antigen recall and a concurrent decrease in TH17 cell subset frequencies compared to low responders. The presence of a γδ T cell subset displaying polyfunctional cytokine responses was also associated with better vaccine response in the elderly. This comprehensive analysis sheds light on inherent differences in immune cell frequencies and functions that should offer insights for targeted vaccination strategies in older populations.
- Open Access
- 23 January 2023
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 19 (1) , e1010860
A real-time regional model for COVID-19: Probabilistic situational awareness and forecasting
The COVID-19 pandemic is challenging nations with devastating health and economic consequences. The spread of the disease has revealed major geographical heterogeneity because of regionally varying individual behaviour and mobility patterns, unequal meteorological conditions, diverse viral variants, and locally implemented non-pharmaceutical interventions and vaccination roll-out. To support national and regional authorities in surveilling and controlling the pandemic in real-time as it unfolds, we here develop a newregionalmathematical and statistical model. The model, which has been in use in Norway during the first two years of the pandemic, is informed by real-time mobility estimates from mobile phone data and laboratory-confirmed case and hospitalisation incidence. To estimate regional and time-varying transmissibility, case detection probabilities, and missed imported cases, we developed a novel sequential Approximate Bayesian Computation method allowing inference in useful time, despite the high parametric dimension. We test our approach on Norway and find that three-week-ahead predictions are precise and well-calibrated, enabling policy-relevant situational awareness at a local scale. By comparing the reproduction numbers before and after lockdowns, we identify spatially heterogeneous patterns in their effect on the transmissibility, with a stronger effect in the most populated regions compared to the national reduction estimated to be 85% (95% CI 78%-89%). Our approach is the first regional changepoint stochastic metapopulation model capable of real time spatially refined surveillance and forecasting during emergencies.
- 23 January 2023
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 19 (1) , e1010860
Open AccessA real-time regional model for COVID-19: Probabilistic situational awareness and forecasting
The COVID-19 pandemic is challenging nations with devastating health and economic consequences. The spread of the disease has revealed major geographical heterogeneity because of regionally varying individual behaviour and mobility patterns, unequal meteorological conditions, diverse viral variants, and locally implemented non-pharmaceutical interventions and vaccination roll-out. To support national and regional authorities in surveilling and controlling the pandemic in real-time as it unfolds, we here develop a newregionalmathematical and statistical model. The model, which has been in use in Norway during the first two years of the pandemic, is informed by real-time mobility estimates from mobile phone data and laboratory-confirmed case and hospitalisation incidence. To estimate regional and time-varying transmissibility, case detection probabilities, and missed imported cases, we developed a novel sequential Approximate Bayesian Computation method allowing inference in useful time, despite the high parametric dimension. We test our approach on Norway and find that three-week-ahead predictions are precise and well-calibrated, enabling policy-relevant situational awareness at a local scale. By comparing the reproduction numbers before and after lockdowns, we identify spatially heterogeneous patterns in their effect on the transmissibility, with a stronger effect in the most populated regions compared to the national reduction estimated to be 85% (95% CI 78%-89%). Our approach is the first regional changepoint stochastic metapopulation model capable of real time spatially refined surveillance and forecasting during emergencies.
- Open Access
- 13 October 2022
- Published by Taylor & Francis in Infectious Diseases
- Vol. 54 (12) , 934-939
No evidence for added value of introducing mandatory COVID-19 testing for international travellers entering Norway with a valid EU digital COVID certificate
As a response to the emergence of the new Omicron SARS-CoV-2 variant, on December 3, 2021, mandatory testing after entry to Norway was extended to include international travellers with a valid COVID-19 certificate. We aim to validate if mandatory testing upon arrival increased the proportion of travellers confirmed with a positive COVID-19 test after entry. We used individual level data on registered travellers linked with data on COVID-19 testing and confirmed COVID-19 cases. The proportions of confirmed cases among international travellers before and after the requirement were introduced was analysed with an interrupted times series design. The proportion of travellers with an EU COVID-19 certificate tested at an official test station increased from 3% to 43% after mandatory testing was introduced. However, the proportion of all travellers confirmed with COVID-19 rose only marginally with 0.14 percentage point directly after the intervention (p-value .06). The results are limited by the absence of data on antigen tests taken by the traveller at home and missing data from travellers without a valid Norwegian ID. Our findings suggest that the benefit of mandatory testing of all international travellers to Norway was marginal in the period directly after the emergence of the omicron variant. This result must be understood in the context of free of charge testing at official test centres, a government recommendation on a low threshold to test when experiencing symptoms in addition to limited surveillance of the compliance of the test after arrival requirement.
- 13 October 2022
- Published by Taylor & Francis in Infectious Diseases
- Vol. 54 (12) , 934-939
Open AccessNo evidence for added value of introducing mandatory COVID-19 testing for international travellers entering Norway with a valid EU digital COVID certificate
As a response to the emergence of the new Omicron SARS-CoV-2 variant, on December 3, 2021, mandatory testing after entry to Norway was extended to include international travellers with a valid COVID-19 certificate. We aim to validate if mandatory testing upon arrival increased the proportion of travellers confirmed with a positive COVID-19 test after entry. We used individual level data on registered travellers linked with data on COVID-19 testing and confirmed COVID-19 cases. The proportions of confirmed cases among international travellers before and after the requirement were introduced was analysed with an interrupted times series design. The proportion of travellers with an EU COVID-19 certificate tested at an official test station increased from 3% to 43% after mandatory testing was introduced. However, the proportion of all travellers confirmed with COVID-19 rose only marginally with 0.14 percentage point directly after the intervention (p-value .06). The results are limited by the absence of data on antigen tests taken by the traveller at home and missing data from travellers without a valid Norwegian ID. Our findings suggest that the benefit of mandatory testing of all international travellers to Norway was marginal in the period directly after the emergence of the omicron variant. This result must be understood in the context of free of charge testing at official test centres, a government recommendation on a low threshold to test when experiencing symptoms in addition to limited surveillance of the compliance of the test after arrival requirement.
- Open Access
- 4 April 2022
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 150, 1-21
Estimation of the incidence of hospitalisation for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older
The purpose of this study was to estimate simple measures of the burden of non-invasive pneumococcal pneumonia (PnPn) hospitalisations in those aged 50 years and older (50+) in Norway. We conducted a retrospective register-based study and used discharge codes from the Norwegian Patient Register (NPR). We identified episodes of non-invasive PnPn in 2015 to 2016 and predicted its incidence from 2015 to 2019 based on the trend found in notified invasive pneumococcal disease cases. Overall, we identified 45–46 hospital episodes per 100 000 population of non-invasive PnPn in 2015 and 2016, each episode taking 6–8 days, and with increasing incidence with higher age. Among all identified PnPn episodes, 3 out of 4 were classified as non-invasive. We predicted that the monthly number of non-invasive PnPn episodes ranges from 39 [95% confidence interval (CI) 24–55] in August to 97 (95% CI 74–134) in December. No annual trend was identified. This study indicates that the burden of non-invasive PnPn hospitalisation has a substantial impact on the health and health care use of the 50+ population in Norway, despite the childhood immunisation programme. Many hospitalisations may be prevented through vaccination.
- 4 April 2022
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 150, 1-21
Open AccessEstimation of the incidence of hospitalisation for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older
The purpose of this study was to estimate simple measures of the burden of non-invasive pneumococcal pneumonia (PnPn) hospitalisations in those aged 50 years and older (50+) in Norway. We conducted a retrospective register-based study and used discharge codes from the Norwegian Patient Register (NPR). We identified episodes of non-invasive PnPn in 2015 to 2016 and predicted its incidence from 2015 to 2019 based on the trend found in notified invasive pneumococcal disease cases. Overall, we identified 45–46 hospital episodes per 100 000 population of non-invasive PnPn in 2015 and 2016, each episode taking 6–8 days, and with increasing incidence with higher age. Among all identified PnPn episodes, 3 out of 4 were classified as non-invasive. We predicted that the monthly number of non-invasive PnPn episodes ranges from 39 [95% confidence interval (CI) 24–55] in August to 97 (95% CI 74–134) in December. No annual trend was identified. This study indicates that the burden of non-invasive PnPn hospitalisation has a substantial impact on the health and health care use of the 50+ population in Norway, despite the childhood immunisation programme. Many hospitalisations may be prevented through vaccination.
- 12 October 2020
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 55 (11) , 1291-1300
eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis
Microbial dysbiosis in inflammatory bowel disease (IBD) is poorly understood. Faecal samples collected for the purposes of microbiota analysis are not yet a part of everyday clinical practice. To e...
- 12 October 2020
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 55 (11) , 1291-1300
eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis
Microbial dysbiosis in inflammatory bowel disease (IBD) is poorly understood. Faecal samples collected for the purposes of microbiota analysis are not yet a part of everyday clinical practice. To e...